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Abstract
Background: Fetal Growth Restriction is often associated with a feto-placental vascular dysfunction conceivably involving
endothelial cells. Our study aimed to verify this pathogenic role for feto-placental endothelial cells and, coincidentally,
demonstrate any abnormality in the nitric oxide system.
Methods: Prenatal assessment of feto-placental vascular function was combined with measurement of nitric oxide (in the
form of S-nitrosohemoglobin) and its nitrite byproduct, and of the endogenous nitric oxide synthase inhibitor asymmetric
dimethylarginine. Umbilical vein endothelial cells were also harvested to determine their gene profile. The study comprised
term pregnancies with normal (n = 40) or small-for-gestational-age (n = 20) newborns, small-for-gestational-age preterm
pregnancies (n = 15), and bi-chorial, bi-amniotic twin pregnancies with discordant fetal growth (n = 12).
Results: Umbilical blood nitrite (p,0.001) and S-nitrosohemoglobin (p = 0.02) rose with fetal growth restriction while
asymmetric dimethylarginine decreased (p = 0.003). Nitrite rise coincided with an abnormal Doppler profile from umbilical
arteries. Fetal growth restriction umbilical vein endothelial cells produced more nitrite and also exhibited reciprocal changes
in vasodilator (upwards) and vasoconstrictor (downwards) transcripts. Elevation in blood nitrite and S-nitrosohemoglobin
persisted postnatally in the fetal growth restriction offspring.
Conclusion: Fetal growth restriction is typified by increased nitric oxide production during pregnancy and after birth. This
response is viewed as an adaptative event to sustain placental blood flow. However, its occurrence may modify the
endothelial phenotype and may ultimately represent an element of risk for cardiovascular disease in adult life.
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Introduction
Fetal growth restriction (FGR) complicates up to 8% of
pregnancies and carries high perinatal morbidity and mortality.
[1] Infants born as small-for-gestational-age (SGA) also present a
greater risk for cardiovascular disease during adulthood. [2] No
definite explanation is available for the latter occurrence, although
a deranged prenatal or perinatal programming of certain
mechanisms [3,4,5] may be involved.
An alteration of the feto-placental circulation, reportedly
involving the endothelium, plays a key part in the onset and
progression of FGR. [6] Among the several agents controlling this
vascular district, nitric oxide (NO) appears most important for its
known role under normal conditions and as a target for
pathological insults, [7] including possibly events that are
identified with the development of FGR.8,9 However, besides
being impaired by a variety of stimuli, NO may also have a
compensatory function, and several situations in the adult
document this possibility. [8].
Our objective was to study NO function in pregnancies
complicated by FGR. The approach was comprehensive and
included: (i) measurement of NO and its main metabolite,
nitrite (NO2), along with the natural NO synthase inhibitor
asymmetric dimethylarginine (ADMA); (ii) analysis of Doppler
velocimetry in umbilical arteries; and (iii) assessment of gene
profile in umbilical vein endothelial cells (HUVEC) collected at
the time of delivery. Our ultimate aim was to define the nature
of any linkage between NO and FGR and, coincidentally,
provide a possible insight into the alleged negative impact of
FGR on adult health.
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Figure 1. NO2, NOHb and ADMA levels in umbilical blood from pregnancies with normal or restricted fetal growth. Umbilical vein and
artery levels of NO2 (A, B), NOHb (C, D) and ADMA (E, F) at different BW centiles: 75
th–25th (black circles); ,25th–10th (black and white circles);
,10th–3rd (white circles); ,3rd (white squares). Dashed line presents the exponential or linear relationship between these variable and BW. *p,0.05;
**p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0045294.g001
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Materials and Methods
Study Groups
The study comprised three groups. Group 1: pregnancies
being scheduled for umbilical Doppler velocimetry at 36 wk and
yielding term infants with average (AGA) and small-for-
gestational age (SGA; ,2.5 kg at term or ,10th percentile
body weight) body weight (BW) (n = 60). Group 2: pregnancies
with isolated preterm FGR (,10th percentile body weight; mean
gestational age 3461 wk, n= 15). Group 3: bi-chorionic, bi-
amniotic twin pregnancies with offspring of discordant growth
(mean gestational age 3562 wk, n = 12 pregnancies). All patients
included in the study were normotensive. A subset of neonates
(n = 45, equally distributed among the groups 1 and 2) were
subdivided according to BW in normal (75th–25th centile)
(n = 15), at the limit of normality (,25th–10th centile) (n = 15)
and in the SGA category (,10th centile, with ,3rd centile being
considered a severe SGA, n= 15). Mean 6 SD of BW centiles
for each group was as follows: 75th–25th centile: 52.82614.45;
,25th–10th centile: 17.1364.23; ,10th–3rd centile: 8.2461.75;
,3rd centile: 1.6160.51. BW profile for the population is given
in Fig. S1. SGA infants were further characterized by the
Rohrer’s ponderal index (PInd) (weight in grams* 100/length in
cm3). Average PInd with appropriate-for-gestational age infants
at term is 2.4. [9] PInd decreases with FGR, because abdominal
growth lags behind the increase in length (asymmetric growth).
Thus, in its low range PInd can be used to characterize further
the grade of FGR in newborns. Cord blood (artery and vein) was
collected in all cases, while peripheral blood (heel sampling) was
obtained from certain newborns at the time of delivery and 24 or
72 h afterwards. Blood being left after routine procedures was
used for the latter purpose. Clinical characteristics of groups and
demographic details are found in Tables S1, S2, and S3.
Ethics Statement
All participants provided written informed consent. Parents
provided written approval for the procedures on the newborns,
which did not add to the standard routine. The Ethics Committee
of the University of Pisa approved protocol and procedures of the
study.
Doppler Velocimetric Analysis
Doppler ultrasound analysis was performed on the umbilical
arteries with a Technos scanner (Esaote Biomedica, Genova, Italy)
being equipped with color flow imaging, pulsed Doppler capability
and convex probes (3.5–5 MHz for transabdominal examination).
Records were stored for subsequent retrieval, and the same person
(F.A.L.S.) was responsible for all the examinations.
Figure 2. NO2, NOHb and ADMA levels in umbilical blood from pregnancies with symmetric or asymmetric fetal growth restriction.
Umbilical vein and artery levels of NO2 (A), NOHb (B) and ADMA (C) in pregnancies with fetuses below 10th centile BW. Vertical dashed line separates
groups with asymmetric (PInd ,2) and symmetric (PInd .2) growth restriction. *p,0.05; **p,0.01; ***p,0.001 for ,2 vs. .2 PInd groups.
doi:10.1371/journal.pone.0045294.g002
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Patients were studied in recumbent position after a 10-min rest.
The result was labeled as abnormal in the case of absent or
reversed end-diastolic flow. Similarly abnormal was considered
any end-diastolic flow, with a peak-systolic/end-diastolic velocity
ratio exceeding the mean value of the group by 2 SD.
Cell Culture
HUVEC from a subset of patients (n = 36, equally distributed
among the indicated groups) were isolated at the time of delivery
and were grown in culture according to a previous protocol [10]
for measurement of endothelial nitric oxide synthase (eNOS)
protein and activity. Miniarray analysis was performed on the
same population of cells.
Analytical Procedures
NO content of blood was assessed by measuring NO2 [10] and
nitroso-hemoglobin (NOHb). The latter assay was carried out with
the X-band electron paramagnetic resonance spectrometer
ALEXIS (Bruker Biospin, Karlsruhe, Germany) in a high
sensitivity microwave cavity. [11] Whole blood with known
concentrations of NO2 (1–10 mM) and Na2S2O4 (20 mM) served
as a reference. [12] ADMA was assayed in the same samples with
a commercial kit (Pantec, Torino, Italy). eNOS activity of
HUVEC was derived from the degree of arginine-to-citrulline
conversion, [10] and NO2 was measured in parallel in the cell
incubate.
Western Immunoblotting
HUVEC lysates were separated by SDS-PAGE and then
subjected to immunoblotting for eNOS. Briefly, the primary
antibody (rabbit anti-human eNOS, 1:1000; Transduction Labo-
ratories, Lexington, KY) was incubated with the blotted
membranes overnight at 4uC and blots were subsequently
hybridized with a secondary antibody (goat anti-rabbit, 1:4000;
Transduction Laboratories). b-Actin (Santa Cruz Biotechnology,
Santa Cruz, CA) served as reference. The resulting chemilumi-
nescent signal was recorded with a quantitative digital imaging
system capable of recognizing any saturation of the input
(Quantity One; BioRad, Hercules, CA). Results are given as the
eNOS/b-actin ratio in arbitrary units (control = 1), with conditions
ensuring the reading of signals over a linear range.
Miniarray Analysis
Total RNA was extracted from HUVEC with the guanidine
thiocianate-phenol-chloroform mixture, and hybridization of an
aliquot (4 mg) was performed with Human Endothelial Cell
Biology Oligo GEArrays (Superarray Biosciences, Frederick,
USA). Singleton pregnancies being scheduled for umbilical
Doppler velocimetry at 36 wk and yielding term infants with
average (AGA) body weight were studied comparatively with
isolated severe FGR singleton pregnancies (n = 6 per group). A
total of 114 genes were examined (Table S4), all being selected for
their general relevance to endothelial function. Gene expression
was measured by chemiluminescence, taking care to ensure the
same exposure for each membrane. Quantitative analysis was
obtained with a digital system excluding any saturation (Quantity
One; BioRad). The signal for each gene was measured against
housekeeping genes incorporated into the system, as recom-
mended by the manufacturer. Background noise was also
Figure 3. eNOS protein and activity in HUVEC from pregnancies with normal or restricted fetal growth. eNOS protein and activity, and
NO2 content of incubate for HUVEC collected at different BW centiles (A, B). Values at (C) apply to different PInd grades within the 10
th centile BW
group. *p,0.05; **p,0.01; ***p,0.001 vs. 75th–25th centile (A, B) or 2.68–2.74 PInd (C).
doi:10.1371/journal.pone.0045294.g003
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subtracted in the process. A 5-fold change of expression in either
direction was taken as the limit for acceptance of data.
Statistics
Data are presented as the mean6 SD. Comparisons were made
using Student’s t-test or ANOVA followed by the Tukey test.
Regression analysis was performed with the best fitting for a linear
or exponential relationship. Differences are considered significant
with p,0.05.
Results
NO2, NOHb and ADMA in Umbilical Blood
Regression analysis showed a significant inverse relationship
with exponential course between NO2 levels in the umbilical vein
and growth of newborns (R2= 0.809; p,0.001, Fig. 1A). NO2
elevation was particularly marked with BW below the 10th centile
(Fig. 1A). A similar pattern emerged from umbilical artery
sampling, but the magnitude of the NO2 change was smaller
and a linear inverse relationship between NO2 and BW values was
evident only from the 25th centile downwards (R2 = 0.262;
p = 0.018, Fig. 1B).
NOHb was also elevated in umbilical blood of FGR pregnan-
cies, regardless of whether it originated from the artery or the vein
(Figg. 1C and 1D). However, at variance from NO2, the inverse
relationship linking NOHb with BW was linear with the vein
(R2 = 0.169; p = 0.024, Fig. 1C) and exponential with the artery
(R2 = 0.705; p,0.001, Fig. 1D).
Contrary to NO2 and NOHb, changes in ADMA levels were
less consistent and varied in sign depending on vessel and degree of
FGR. As shown in Fig. 1E, findings with the umbilical vein
paralleled those for NO-related variables, and a linear inverse
relationship linked ADMA content with BW (R2= 0.226;
p = 0.003). No such relationship was noted instead with the
umbilical artery (Fig. 1F), and ADMA was either decreased (,10th
centile) or marginally increased (,25th –10th centile).
A separate analysis was carried out with SGA pregnancies of
BW below the 10th centile, where levels of compounds in umbilical
vein and artery were correlated with the PInd of infants. For this
purpose, a PInd of 2 was taken as the dividing limit between
symmetric and asymmetric growth groups (see Methods). As
shown in Fig. 2, pregnancies with PInd below 2 had significantly
higher amounts of NO2 and NOHb in both vessels. Conversely,
under the same conditions ADMA level was lower only in the
umbilical artery.
eNOS Function in HUVEC
eNOS protein expression and activity and NO2 release were
significantly higher in HUVEC from the 25th centile BW group
downwards (Fig. 3A and 3B). Furthermore, the same pattern was
Figure 4. Prenatal umbilical artery Doppler velocimetry vs. NO function in fetuses with normal or restricted growth. Blood levels of
NO2 (A), NOHb (B), and ADMA (C) for umbilical vein and artery with normal (N) vs. abnormal (Abn) Doppler velocimetry in term (T) or preterm (PT)
pregnancies. Note that number of patients is low for certain groups (n = 1 or 2; see columns without SD bar), while n = 3–18 for the remainder. HUVEC
from pregnancies with normal vs. abnormal Doppler: eNOS activity with attendant NO2 formation (D) (n = 3–4) and eNOS protein expression (E)
(n = 2). *p,0.05; **p,0.01 vs. normal Doppler.
doi:10.1371/journal.pone.0045294.g004
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seen when relating these variables to the PInd of newborns with
BW below the 10th centile. Fig. 3C documents this point, even
though the subset of pregnancies was distributed over a relatively
narrow range compared to that considered in Fig. 2.
Umbilical Artery Doppler Analysis vs. NO Markers in
Umbilical Blood and Cells from Pregnancies with Normal
or Restricted Fetal Growth
A subset of the patients, including preterm and term pregnan-
cies with FGR, also had a Doppler velocimetric analysis of the
umbilical arteries. Limited to this group, NO2 levels in umbilical
vein and artery blood were increased with an abnormal Doppler
profile (Fig. 4A), while in contrast NOHb and ADMA levels were
decreased (Fig. 4B and 4C). This finding appeared to be
independent of fetal growth status or gestational age. In addition,
eNOS protein and activity in HUVEC, with the attendant NO2 in
the incubate, were elevated when dealing with SGA pregnancies
with Doppler derangement (Fig. 4D and 4E).
NO2 and NOHb in Umbilical Blood from Twins with
Discordant Intrauterine Growth
Umbilical vein NO2 did not differ between normal (NT) and
small (ST) twin when Doppler analysis was normal (Fig. 5A), while
in contrast the compound was elevated in the umbilical artery of
the small twin (Fig. 5B). No difference between the two vessels was
noted with an abnormal Doppler, and NO2 levels were
consistently higher in the SGA infant of the pair (Fig. 5A and 5B).
NOHb, on the other hand, was elevated in both umbilical
vessels of the SGA infant even in the absence of any anomaly in
the velocimetric analysis (Fig. 5C and 5D). However, when SGA
was associated with an abnormal Doppler, NOHb abated in the
umbilical artery (Fig. 5D) and tended to rise in the vein (Fig. 5C).
Blood levels of ADMA in either vessel did not differ, regardless of
BW and the state of umbilical artery blood flow (data not shown).
Blood NO2 and NOHb in Newborns with Normal or
Restricted Growth
As shown in Fig. 6 (A, B), newborns below the 25th centile
presented a marked increase in blood NO2 and NOHb at 24 h of
age which, in certain cases, was maintained up to the 72-h.
Conversely, a modest elevation, only for (NO2), or no elevation at
all was seen in the normal offspring. Furthermore, infants with an
abnormal Doppler profile tended to have higher levels of blood
NO with both term and preterm pregnancies (Fig. 6C). No such
correlation was noted in the case of NOHb (Fig. 6D).
Gene Profile in HUVEC from Fetuses with Normal or
Restricted Growth
A group of 26 transcripts, out of a total of 114, changed their
expression in either direction in HUVEC from SGA vs. AGA
pregnancies (Fig. 7A–D). In particular, lesser expression was
observed for angiotensin I converting enzyme 1 and 2 (ACE1 and
ACE2) and angiotensin II receptor type 2 (AGTR2), while NOS
enzymes and prostaglandin endoperoxide synthase-2 (PTGS2)
were increased (Fig. 7A). SGA cells also presented a down-
regulation of pro-angiogenetic factors, such as endothelial cell
growth factor-1 (ECGF1), interleukin-1b (IL1B), interleukin-8
(IL8) and VEGF receptor (KDR) (Fig. 7B). Conversely, the anti-
angiogenetic factor thrombospondin-1 (THBS1) was increased
(Fig. 7B). Metalloproteinases (MMP) 1 and 2, collagen type XVIII
Figure 5. NO2 and NOHb levels in umbilical blood from twins with discordant intrauterine growth. NO2 (A, B) and NOHb (C, D) in
umbilical vein and artery blood. NT: twin with normal growth; ST: twin with restricted growth. Note that points for each set of twins are connected by
a line. *p,0.05; **p,0.01 vs. normal twin.
doi:10.1371/journal.pone.0045294.g005
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alpha 1 (COL18A) and platelet factor 4 (PF4) were down-
regulated, while the tissue inhibitor of metalloproteinase-1
(TIMP1) was up-regulated (Fig. 7C). Lastly, HUVEC from SGA
pregnancies exhibited a differential pattern for inflammatory/
adhesion genes (Fig. 7D). Specifically, the up-regulation of
intercellular adhesion molecule-3 (ICAM3), vascular cell adhesion
molecule-1 (VCAM1), integrin-b1 (ITGB1), FAS ligand (FASLG)
and VE-cadherin (CDH5) vis-a`-vis the down-regulation of annexin
A5 (ANXA5), L-selectin (SELL) and platelet/endothelial cell
adhesion molecule-1 (PECAM1) (Fig. 7D).
Discussion
Our study shows activation of the NO system in pregnancies
with FGR, specifically when placental vascular resistance is
impaired. Elevation of NO2 and NOHb is ascribed to enhanced
eNOS activity, within and outside the placenta. This adaptive
response presents distinctive features in HUVEC where appro-
priate changes are seen in genes controlling blood flow,
angiogenesis, extracellular matrix remodeling and inflammation.
Furthermore, a NO enhancement is also evident after birth.
Hence, findings suggest the existence of a re-programming of the
feto-placental vascular system, and of the fetus as a whole, in the
face of adverse intrauterine conditions. Expectedly, its immediate
purpose is to preserve an adequate placental blood flow. An open
question, however, is whether this event translates into a
conditioning process for SGA newborns and, as a corollary, into
an element of risk later in life. A possibility in this respect is that, in
line with evidence from other sites [13,14], an extended activation
of the NO system is followed by down-regulation, specifically of
vascular eNOS. The relative hyperoxia of the neonate would favor
any such occurrence through depletion of tetrahydrobiopterin
(BH4) secondary to oxygen radical formation. [15] Recent data in
the rat are also consistent with the idea of an altered hemodynamic
control in the adult resulting from FGR-linked NO dysfunction.
[16] If confirmed, this concept could open the way to new
Figure 6. Time-related change in peripheral blood levels of NO2 and NOHb in AGA and SGA newborns. Blood levels of NO2 (A, C) and
NOHb (B, D) in relation to BW centile (A, B) and prenatal Doppler finding (C, D) at different time intervals after birth. BW centile: 75th–25th (black
circles);,25th–10th (black and white circles); ,10th–3rd (white circles);,3rd (white squares). Doppler finding for term (T) and preterm (PT) pregnancy:
normal (white circles) and abnormal (black circles) with each point representing a single patient. *p,0.05; **p,0.01; ***p,0.001 for 24- and 72- h
intervals relative to time zero. Note that, in the aggregate, NO2 and NOHb values for 75
th–25th centile are significantly different from the other groups
(p,0.001) at the 24- and 72-h time intervals, the only exception being the NOHb value for the ,3rd centile at the 72-h mark (p = 0.068).
doi:10.1371/journal.pone.0045294.g006
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therapeutic strategies, based on BH4 supplementation and/or free
radical scavenging, to improve the postnatal adaptation of SGA
infants.
The source of NO2 in the feto-placental circulation of FGR
pregnancies remains to be determined. Pregnancies complicated
by FGR show increased eNOS expression in syncytiotrophoblast
cells. [17] Our finding of greater eNOS and iNOS expression in
HUVEC confirms the importance of any up-regulation of NOS
transcript(s) in the adaptation of the feto-placental vascular district
to FGR. One should mention, however, that a reduction of eNOS
activity has also been reported, [18] hence highlighting how this
enzyme may be conditioned by a host of factors with opposing
effects. A related question is whether agents that inhibit eNOS,
such as ADMA, [19] are causally linked to FGR, in analogy to
observations made with pre-eclampsia. [20] We found that, in the
case of FGR, ADMA levels are decreased in the umbilical artery,
while the opposite occurs in the vein. This finding accords with the
idea of the fetus being able to reset its NO system upwards, and
this event, along with a decreased production of ADMA, is
conceivably crucial in preserving placental vascular flow. Any such
resetting also applies to pregnancies with a severely growth-
restricted fetus, where the decreasing ponderal index coincides
with higher amounts of NO2 and NOHb in the umbilical vein.
Indeed, this particular relationship is also evident after birth, since
infants belonging to the low-centile groups (,25th centile) present
a more active NO system compared to those within a normal
range (75th–25th centile).
Significantly, we identified erythrocyte-based NOHb as a
potential source for the elevated NO in FGR, even in conditions
of altered feto-placental resistance. Methodologically, the mea-
surement of NOHb has been introduced as a suitable way to
monitor circulating NO in animals and humans. [12] Our report
highlights how this novel technique can be exploited to assess NO
function during pregnancy, with the attendant possibility of better
defining clinical conditions such as an altered feto-placental
vascular resistance or FGR. The existence, in fact, of a good
matching between NO2/NOHb levels in the feto-placental
Figure 7. Gene profile in HUVEC from SGA vs. AGA pregnancies. Comparison of gene expression at 75th-25th (black squares) vs. ,3rd (white
squares) BW centile. Figure reports transcripts being affected by fetal growth restriction that relate to hemodynamic control (A), angiogenesis (B),
extracellular matrix turnover (C) and inflammatory/adhesion process (D). Values are expressed as the intensity ratio between test and reference
genes (for details, see Methods). Note that the total gene cohort under examination is given in Table S4. *p,0.05; **p,0.01; ***p,0.001 for ,3rd vs.
75th–25th BW centile.
doi:10.1371/journal.pone.0045294.g007
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circulation and indices of vascular resistance/flow provides the
basis for any such approach.
NO function in FGR is sustained, in part, by an enhanced
eNOS activity in feto-placental endothelial cells. Our analysis
suggests the occurrence of a reset in endothelial function, being
directed to the maintenance of blood flow in umbilical vessels. A
qualifying event in this process is the reciprocal variation in eNOS
(upwards) and angiotensin-converting enzyme/angiotensin recep-
tor (downwards) expression. Coincidentally, HUVEC from SGA
pregnancies manifest a gene expression pattern that would be
unfavorable for angiogenesis and vascular remodeling. Some of
these gene products – VEGF, VCAM-1 and ICAM-1– have
previously been implicated in FGR or pre-eclampsia and have also
been assigned predictive value for these conditions. [21,22,23] The
overall picture emerging from these data is that feto-placental
endothelial cells play a complex role in the pathophysiology of
FGR, possibly by contributing to processes that limit the
development of the placenta and its responsiveness to hypoxia.
Demonstration of a differential relationship between BW and
umbilical blood levels of NO2 and NOHb in twins with discordant
growth further supports a prime role of the feto-placental
vasculature, and the fetus as a whole, in the natural course of
FGR. Maternal factors are, in fact, common to the two situations
and cannot account for the observed differences.
Conclusion
In conclusion, we find that FGR pregnancies present an
adjustment in the NO system being characterized by elevation of
NO2 and NOHb and reduction of ADMA. Endothelial cells of the
feto-placental circulation are part of this response through a
phenotypic change that attests to growth restriction and hemody-
namic dysfunction. Assessment of NO function in the clinical
setting could become important for the prevention and manage-
ment of FGR. Furthermore, if future studies were to confirm that
changes in the NO system in SGA infants are linked to increased
susceptibility to cardiovascular disorders later in life, new strategies
may ensue for identification of individuals at risk and introduction
of preventive measures.
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